INDOCO REMEDIES FDA Approval ANDA 206153

ANDA 206153

INDOCO REMEDIES

FDA Drug Application

Application #206153

Application Sponsors

ANDA 206153INDOCO REMEDIES

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 0.5MG BASE0RASAGILINE MESYLATERASAGILINE MESYLATE
002TABLET;ORALEQ 1MG BASE0RASAGILINE MESYLATERASAGILINE MESYLATE

FDA Submissions

UNKNOWN; ORIG1AP2019-10-04STANDARD
LABELING; LabelingSUPPL2AP2021-01-14STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

INDOCO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206153
            [companyName] => INDOCO
            [docInserts] => ["",""]
            [products] => [{"drugName":"RASAGILINE MESYLATE","activeIngredients":"RASAGILINE MESYLATE","strength":"EQ 0.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"RASAGILINE MESYLATE","activeIngredients":"RASAGILINE MESYLATE","strength":"EQ 1MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/04\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-10-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.